Alto Neuroscience Inc.

NYSE: ANRO · Real-Time Price · USD
3.15
0.03 (0.96%)
At close: Aug 15, 2025, 3:59 PM
3.14
-0.32%
After-hours: Aug 15, 2025, 05:05 PM EDT

Alto Neuroscience Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-61.43M -36.3M -27.71M -9.19M
Depreciation & Amortization
502K 373K 342K 145K
Stock-Based Compensation
7.63M 2.89M 1.76M 227K
Other Working Capital
3.54M -391K 2.42M 255K
Other Non-Cash Items
1.81M 291K 632K 125K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
4.06M -698K 4.58M -572K
Operating Cash Flow
-47.42M -33.45M -20.39M -9.26M
Capital Expenditures
-2.08M -470K -732K -680K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-2.08M -470K -732K -680K
Debt Repayment
1.25M n/a 9.82M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-3.14M -2.05M -341K n/a
Financial Cash Flow
135.69M 68.13M 43.79M 31.69M
Net Cash Flow
86.18M 34.2M 22.64M 21.7M
Free Cash Flow
-49.5M -33.92M -21.13M -9.94M